1.54
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Geron Corp | GERN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.04 | -2.53% | 1.54 | 1.50 | 1.59 | 1.59 | 1.58 | 19:59:33 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.53 | 1.58 | 0.05 | 3.16% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,174 | 4,388,977 | $ 1.54 | $ 6,757,037 | 3,368,237 | 0.75 - 2.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:54:21 | 50 | $ 1.54 | USD |
Geron Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 473.41M | 307.41M | 302.49M | $ 460.00k | $ - | -0.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 6.00 | 2.50% |
Geron News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GERN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.72 | 1.79 | 1.50 | 1.59 | 4,153,605 | -0.18 | -10.47% |
| 1 Month | 1.24 | 2.40 | 1.23 | 1.76 | 4,961,129 | 0.30 | 24.19% |
| 3 Months | 1.01 | 2.40 | 0.75 | 1.49 | 2,609,503 | 0.53 | 52.48% |
| 6 Months | 1.49 | 2.40 | 0.75 | 1.42 | 1,925,702 | 0.05 | 3.36% |
| 1 Year | 1.45 | 2.40 | 0.75 | 1.41 | 1,699,199 | 0.09 | 6.21% |
| 3 Years | 2.84 | 6.99 | 0.75 | 2.85 | 3,150,028 | -1.30 | -45.77% |
| 5 Years | 3.88 | 6.99 | 0.75 | 2.92 | 2,680,425 | -2.34 | -60.31% |
Geron Description
| Geron Corp is a clinical stage biopharmaceutical company. Its focus is the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Imelstat is expected to directly obstruct malignant-cell proliferation. |
